Drug discount agreements for the active ingredient Evolocumab (ATC C10AX13)
Drug discount agreements for the active ingredient Evolocumab (ATC C10AX13): Conclusion under an Open House model with all interested pharmaceutical companies under uniform, non-exclusive conditions. Maximum contract duration 24 months, earliest contract start 01.09.2026. All contracts end no later than 24 months after the earliest contract start. Accession or contract conclusion is possible monthly on the first day. Right of termination exists with 6 weeks' notice to the end of the month. AOK Rheinland-Pfalz/Saarland reserves the right to replace Open House agreements with exclusive agreements. Submission of documents preferably electronically with a qualified electronic signature via email to am_vertraege@rps.aok.de or manually signed in duplicate (scan via email in advance) to AOK Rheinland-Pfalz/Saarland, Strategisches Vertragsmanagement Arzneimittel, Virchowstraße 30, 67304 Eisenberg. Potential contractors are exclusively pharmaceutical companies. For a contract start on 01.09.2026, the submission deadline is 31.07.2026. Later contract conclusions are possible monthly on the first day during the maximum 24-month term, with submission by the end of the month preceding the desired contract start. This publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU.
CONTRACTING AUTHORITY
Name
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
City
Eisenberg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
715 days remaining(LOT-0001)
Published